MedPath

High-dose erythropoietin therapy for the purpose of brain protection in neonatal hypoxic-ischemic encephalopathy

Not Applicable
Recruiting
Conditions
Hypoxic-ischemic encephalopathy
Registration Number
JPRN-UMIN000012689
Lead Sponsor
Osaka Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Congenital malformations, chromosomal abnormalities

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EEG, brain ultrasonography:neonatal period: brain MRI:within 1 month,1year blood exam(Hb,plt):day1,3,7,14,30 18 month:developmental test
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath